263 related articles for article (PubMed ID: 30952481)
1. Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases.
Retnakumar SV; Muller S
Trends Mol Med; 2019 Jun; 25(6):516-537. PubMed ID: 30952481
[TBL] [Abstract][Full Text] [Related]
2. Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives.
Zatorski H; Sałaga M; Fichna J
Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1321-1330. PubMed ID: 31359088
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Bowel Disease Drugs: A Focus on Autophagy.
Hooper KM; Barlow PG; Stevens C; Henderson P
J Crohns Colitis; 2017 Jan; 11(1):118-127. PubMed ID: 27381462
[TBL] [Abstract][Full Text] [Related]
4. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
5. Integrins and adhesion molecules as targets to treat inflammatory bowel disease.
Bravatà I; Allocca M; Fiorino G; Danese S
Curr Opin Pharmacol; 2015 Dec; 25():67-71. PubMed ID: 26687159
[TBL] [Abstract][Full Text] [Related]
6. Development of drugs to target interactions between leukocytes and endothelial cells and treatment algorithms for inflammatory bowel diseases.
Danese S; Panés J
Gastroenterology; 2014 Nov; 147(5):981-9. PubMed ID: 25220794
[TBL] [Abstract][Full Text] [Related]
7. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
[TBL] [Abstract][Full Text] [Related]
8. Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease.
Yokoyama M; Kimura MY; Ito T; Hayashizaki K; Endo Y; Wang Y; Yagi R; Nakagawa T; Kato N; Matsubara H; Nakayama T
Front Immunol; 2020; 11():594297. PubMed ID: 33584659
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review.
Araruna ME; Serafim C; Alves Júnior E; Hiruma-Lima C; Diniz M; Batista L
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233487
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic targets for inflammatory bowel disease.
Argollo M; Fiorino G; Hindryckx P; Peyrin-Biroulet L; Danese S
J Autoimmun; 2017 Dec; 85():103-116. PubMed ID: 28711286
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic potential of carbon monoxide for inflammatory bowel disease.
Takagi T; Uchiyama K; Naito Y
Digestion; 2015; 91(1):13-8. PubMed ID: 25632911
[TBL] [Abstract][Full Text] [Related]
12. Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?
Porter RJ; Andrews C; Brice DP; Durum SK; McLean MH
Inflamm Bowel Dis; 2018 Sep; 24(10):2123-2134. PubMed ID: 30020451
[TBL] [Abstract][Full Text] [Related]
13. Potential role of nutraceutical compounds in inflammatory bowel disease.
Larussa T; Imeneo M; Luzza F
World J Gastroenterol; 2017 Apr; 23(14):2483-2492. PubMed ID: 28465632
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological control of autophagy: therapeutic perspectives in inflammatory bowel disease and colorectal cancer.
García-Mauriño S; Alcaide A; Domínguez C
Curr Pharm Des; 2012; 18(26):3853-73. PubMed ID: 22632751
[TBL] [Abstract][Full Text] [Related]
15. Advances in inflammatory bowel diseases in children.
Michail S; Ramsy M; Soliman E
Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
[TBL] [Abstract][Full Text] [Related]
16. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease.
Chen F; Liu Q; Xiong Y; Xu L
Int J Nanomedicine; 2021; 16():4225-4237. PubMed ID: 34188471
[TBL] [Abstract][Full Text] [Related]
17. SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn's Disease and Peripheral T Cell Reduction.
Fernandes S; Srivastava N; Sudan R; Middleton FA; Shergill AK; Ryan JC; Kerr WG
Front Immunol; 2018; 9():1100. PubMed ID: 29872435
[TBL] [Abstract][Full Text] [Related]
18. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease.
Sreedhar R; Arumugam S; Thandavarayan RA; Karuppagounder V; Watanabe K
Drug Discov Today; 2016 May; 21(5):843-9. PubMed ID: 26995272
[TBL] [Abstract][Full Text] [Related]
19. Role of autophagy in the pathogenesis of inflammatory bowel disease.
Iida T; Onodera K; Nakase H
World J Gastroenterol; 2017 Mar; 23(11):1944-1953. PubMed ID: 28373760
[TBL] [Abstract][Full Text] [Related]
20. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.
Sobczak M; Fabisiak A; Murawska N; Wesołowska E; Wierzbicka P; Wlazłowski M; Wójcikowska M; Zatorski H; Zwolińska M; Fichna J
Pharmacol Rep; 2014 Oct; 66(5):766-75. PubMed ID: 25149979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
